Key motifs (e.g., GYXXQ of IL-10R1) mediate the STAT3 signaling pathway, whose mutations lead to immunodeficiency (e.g., IBD), confirming that coevolution of the ligand–receptor interaction interface is a core mechanism driving immune homeostasis. Here, STAT3 is linked to inflammatory bowel disease.